Global alternative investment manager across credit, private equity and real estate.
Spire Healthcare has agreed to be taken private by Tulip UK, a group backed by Toscafund, THCP Advisory and Ares Management. The deal values Spire at about £1.03bn on a fully diluted basis and includes a plan for a year-long strategic review after completion. Chief executive Justin Ash will step down and be replaced temporarily by Sir David Sloman.
A wave of AI-related IPOs from SpaceX, Anthropic and OpenAI is unfolding, with markets facing a flood of new stock. Retail demand remains strong for SpaceX, but analysts warn supply could overwhelm demand, pressuring prices and testing market resilience.